Sat, May 25, 2013

Anaemia drug darbepoetin alpha does not reduce time to death for heart failure admissions – top line RED-HF® trial results announced

Amgen have revealed that their Phase 3 trial investigating darbepoetin alpha effects in anaemic heart failure patients has ...  More

Baseline hepcidin levels predict non-responsiveness to oral iron therapy in patients with iron deficiency anaemia, researchers conclude

Baseline hepcidin levels are a better predictor of responsiveness to oral iron therapy than TSAT or ferritin measures, a new ...  More

Intravenous iron may have a role in the management of anaemia in cancer patients, potentially reducing the need for erythropoiesis-stimulating agents, new study claims

Monotherapy with ferric carboxymaltose can effectively increase haemoglobin levels with good tolerability in anaemic and iron ...  More

Evolving iron deficiency predicts greater mortality in patients with chronic heart failure, new finding show

Routine erythrocyte indices can predict increased mortality in stable chronic heart failure (CHF) patients, according to a ...  More

Hepcidin may be a key mediator of anaemia of inflammation in Crohn's disease

The liver hormone, hepcidin, may mediate anaemia of chronic disease (ACD) in patients with Crohn’s disease, a new study reports ...  More

Earlier this month, leading experts gathered in Vienna, Austria, to discuss the latest developments in inflammatory bowel disease (IBD) at the annual congress of the European Crohn’s and Colitis Organisation (ECCO).

Iron deficiency played a significant role on the agenda, reflecting the expanding interest and research in this indication and the recognition of the impact of iron deficiency on IBD.

Two key symposia brought together data showing the challenges that exist in iron-deficiency anaemia identification and management in IBD, and detailed some of the factors that contribute to the success of treatment. Numerous poster presentations provided different perspectives on these ...

Full article >>

May 25 to 28, 2013

Lisbon, Portugal

Heart Failure 2013

For more information, please visit the ESC website.

June 1 to 4, 2013

Barcelona, Spain

Euroanaesthesia 2013

For more information, please visit the ESA website.

June 13 to 16, 2013

Stockholm, Sweden

18th Congress of EHA

For more information, please visit the EHA website.

August 31 to September 4, 2013

Amsterdam, The Netherlands

ESC Congress 2013

For more information, please visit the ESC website.

This site complies with the HONcode standard for trustworthy health information:
verify here.